Healthcare
Clearday, Inc.(CLRD)
Live Price
Offline$0.0012
+0.00% today
1Y Change
+140.00%
Window
Jun 25, 2025 โ Jun 16, 2026
- Market Cap
- $70.00M
- Revenue Growth
- -3.1%
- EPS Growth
- +39.5%
- Dividend Yield
- 0.0%
Coverage: 240 bars ยท Jun 25, 2025 โ Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Clearday, Inc. (CLRD) is a Healthcare stock with a market cap of $70.00M and listed on OTC. The stock last traded around $0.00 and up 140.0% across the available one-year price window (Jun 25, 2025 โ Jun 16, 2026). Baseline metrics include revenue growth of -3.1%, EPS growth of +39.5%, a dividend yield of 0.0%. What stands out right now is revenue -3.1%, EPS +39.5%, free cash flow +10.2% with operating margin 0.0% and ROIC -13.9%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CLRD price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-3.1% vs +7.6% peer median
Operating Margin
Below sector median
0.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2025 was reported on Jun 10, 2025, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -3.1% and EPS is at +39.5%, with operating margin around 0.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -60.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2025 Jun 10, 2025 | โ | +0.0% | -60.0% | -80.0% |
2025 Apr 4, 2025 | โ | +0.0% | -60.0% | -80.0% |
2025 Feb 28, 2025 | โ | +0.0% | -60.0% | -80.0% |
Benchmark Edge
CLRD vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CLRD
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CLRD Max Drawdown
-99.60%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CLRD and SPY.
Company Overview
Clearday, Inc.
OTC
Clearday is a non-acute longevity healthcare services company providing tech-enabled care solutions for older Americans, particularly those with cognitive impairments. The company operates residential memory care communities through its Memory Care America subsidiary and offers Clearday Clubs, membership-based adult day care centers providing cognitive enrichment and long-term care alternatives. Its flagship digital platform, Clearday at Home, delivers virtual care management through telehealth and software-as-a-service offerings, featuring customized content for patients and caregivers. Clearday also develops AI-powered robotic companion solutions delivered via Robotics-as-a-Service, alongside therapeutic offerings like Clearday Restore, which combines aromatherapy and massage therapy. The company has strategically shifted toward an asset-light technology-focused model, emphasizing digital and robotic innovations to address the growing care crisis while improving accessibility and affordability of quality care options. Founded in 1987 and headquartered in San Antonio, Texas, Clearday integrates physical care facilities with advanced digital health solutions across mobile, wearable, and robotic platforms.
- Leadership
- Mr. James T. Walesa
- Employees
- 225
- Street Address
- 8800 Village Drive, Suite 106
- Mailing
- San Antonio, TX, 78217
- Region
- San Antonio, TX, United States
- Last Updated
- May 8, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 36.3
- Price/Sales
- โ
- Price/Book
- 36.7
Growth
- Revenue
- -3.1%
- EPS
- +39.5%
- Free Cash Flow
- +10.2%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- -0.5%
- ROIC
- -13.9%
Balance Sheet
- Debt/Equity
- 1.22
- Current Ratio
- 0.00
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.